Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality

被引:42
作者
Soldini, S. [1 ]
Posteraro, B. [2 ]
Vella, A. [1 ]
De Carolis, E. [1 ]
Borghi, E. [4 ]
Falleni, M. [5 ]
Losito, A. R. [3 ]
Maiuro, G. [3 ]
Trecarichi, E. M. [3 ]
Sanguinetti, M. [1 ]
Tumbarello, M. [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, Inst Microbiol, Largo Francesco Vito 1, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, Inst Publ Hlth, Sect Hyg, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, Inst Infect Dis, Rome, Italy
[4] Univ Milan, Dept Hlth Sci, Lab Microbiol, Milan, Italy
[5] Univ Milan, Div Human Pathol, Milan, Italy
关键词
Candida parapsilosis; Drug resistance; Mortality; Targeted therapy; BLOOD-STREAM INFECTION; ANTIFUNGAL SUSCEPTIBILITY; INVASIVE CANDIDIASIS; FUNGAL BIOFILMS; EPIDEMIOLOGY; MANAGEMENT; SPP; ANIDULAFUNGIN; SURVEILLANCE; GUIDELINE;
D O I
10.1016/j.cmi.2017.11.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Biofilm formation (BF) by fungal isolates may dramatically complicate infection. We determined the ability of Candida parapsilosis isolates from single fungaemia episodes to form biofilms and we analysed biofilm subgroups for antifungal susceptibility and pathogenic potential. We then correlated BF with clinical characteristics and outcomes of the episodes. Methods: BF was measured using the crystal violet biomass assay. Antifungal susceptibility of preformed biofilms was assessed, and virulence was studied using the Galleria mellonella model. A retrospective analysis of patients' clinical records was performed. Results: Of 190 patient-unique isolates, 84, 38 and 68 were identified as having high BF (HBF), moderate BF (MBF) or low BF (LBF), respectively. Among 30 randomly selected isolates, nine (eight HBF and one MBF), six (all HBF) and one (HBF) isolates had elevated sessile minimum inhibitory concentrations to fluconazole, anidulafungin or amphotericin B; all HBF and MBF isolates had elevated voriconazole sessile minimum inhibitory concentrations. G. mellonella killing rates of HBF isolates were significantly greater than MBF (or LBF) isolates (50% vs. 20%, 2 days from infection). By comparing HBF/MBF (106 patients) and LBF (84 patients) groups, we found that HBF/MBF patients had more central venous catheter-related fungaemias (62/106 (58.5%) vs. 29/84 (34.5%), p 0.001) and were more likely to die at 30 days from fungaemia onset (61/106 (57.5%) vs. 28/84 (33.3%), p 0.01). In the HBF/MBF group, azole antifungal therapy and central venous catheter removal were significantly associated with a higher and lower 30-day mortality rate, respectively. Conclusions: C. parapsilosis BF influences the clinical outcome in patients with fungaemia. (c) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:771 / 777
页数:7
相关论文
共 41 条
[11]   Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis [J].
Fernandez-Ruiz, Mario ;
Maria Aguado, Jose ;
Almirante, Benito ;
Lora-Pablos, David ;
Padilla, Belen ;
Puig-Asensio, Mireia ;
Montejo, Miguel ;
Garcia-Rodriguez, Julio ;
Peman, Javier ;
Perez de Pipaon, Maite Ruiz ;
Cuenca-Estrella, Manuel .
CLINICAL INFECTIOUS DISEASES, 2014, 58 (10) :1413-1421
[12]   In Vitro Activities of Anidulafungin and Other Antifungal Agents against Biofilms Formed by Clinical Isolates of Different Candida and Aspergillus Species [J].
Fiori, Barbara ;
Posteraro, Brunella ;
Torelli, Riccardo ;
Tumbarello, Mario ;
Perlin, David S. ;
Fadda, Giovanni ;
Sanguinetti, Maurizio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) :3031-3035
[13]   Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies [J].
Kontoyiannis, Dimitrios P. ;
Bassetti, Matteo ;
Nucci, Marcio ;
Capparella, Maria Rita ;
Yan, Jean L. ;
Aram, Jalal ;
Hogan, Patricia A. .
MYCOSES, 2017, 60 (10) :663-667
[14]   Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins [J].
Kuhn, DM ;
George, T ;
Chandra, J ;
Mukherjee, PK ;
Ghannoum, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1773-1780
[15]  
Marcos-Zambrano LJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00099-17, 10.1128/AAC.00099-17]
[16]   Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: Comparison of biomass production and metabolic activity and development of cut-off points [J].
Marcos-Zambrano, Laura Judith ;
Escribano, Pilar ;
Bouza, Emilio ;
Guinea, Jesus .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 304 (08) :1192-1198
[17]   Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility [J].
Nieto, M. C. ;
Telleria, O. ;
Cisterna, R. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 81 (01) :34-40
[18]   Microtiter Dish Biofilm Formation Assay [J].
O'Toole, George A. .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2011, (47)
[19]   Characterization of Biofilm Formation and the Role of BCR1 in Clinical Isolates of Candida parapsilosis [J].
Pannanusorn, Srisuda ;
Ramirez-Zavala, Bernardo ;
Luensdorf, Heinrich ;
Agerberth, Birgitta ;
Morschhaeuser, Joachim ;
Romling, Ute .
EUKARYOTIC CELL, 2014, 13 (04) :438-451
[20]   Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection [J].
Pannanusorn, Srisuda ;
Fernandez, Victor ;
Romling, Ute .
MYCOSES, 2013, 56 (03) :264-272